| Literature DB >> 26475478 |
Mohammed Massine El Hammoumi1,2, Omar Slaoui3, Fayçal El Oueriachi3, El Hassane Kabiri3,4.
Abstract
BACKGROUND: This study was conducted to determine the efficacy of surgery in the treatment of complex aspergilloma comparatively with simple aspergilloma.Entities:
Mesh:
Year: 2015 PMID: 26475478 PMCID: PMC4608121 DOI: 10.1186/s12893-015-0103-4
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Flow diagram of population study
| Eligible Patients with lung aspergillosis lesions | |
|---|---|
| Included: | Excluded: |
| -Patient with asergilloma lesions and colmplete CT follow -up | -Patients with poor general state (N=25) |
| -Patient with limited respiratory function ( | |
| -Patient with malignancy: ( | |
| -Absence of follow up ( | |
| -Initial invasive diffuse aspergillosis (N=21) | |
Fig. 1Computed tomographic view of a simple aspergilloma of the right lung
Fig. 2Computed tomographic view of a complex aspergilloma of the left lung
Baseline characteristics of study subjects
| Variables | Group A ( | Group B ( |
|
|---|---|---|---|
| Sexe | |||
| male | 51 | 42 | 0.502 |
| female | 10 | 08 | |
| Age (years) | 39.5±5.2 | 37.8±3.8 | 0.225 |
| BMI* (KG/m2) | 18.8± 2.9 | 22.8±2.6 | 0.002 |
| History of smoking | |||
| never | 19 | 24 | 0.425 |
| Ex | 16 | 11 | 0.269 |
| Unknown | 26 | 15 | 0.013 |
| Pack-years | 18 | 10 | 0.002 |
| Comorbidities: tuberculosis COPD, diabete | 18 | 06 | 0.025 |
| 12 | 03 | 0.004 | |
| Pulmonary function test (FEV* L, % predicted) | 1.8±0.56 | 2.0±0.79 | 0.0015 |
| 68 % ±15 % | 80 % ±10 % | ||
| Aspergilloma Side | |||
| Right | 39 | 29 | 0.356 |
| left | 22 | 19 | 0.247 |
| bilateral | 0 | 2 | 0.350 |
Main indications of surgery in aspergilloma
| Surgical indication | Group A | Group B |
|
|---|---|---|---|
| Recurrent hemoptysis | 50 (81.96 %) | 38 (76 %) | 0.413 |
| Emergency surgery | 04 (6.55 %) | 0 | 0.145 |
| Destroyed parenchyma | 39 (63.93 %) | 12 (24 %) | 0.032 |
| Recurrent infection | 42 (68.85) | 29 (58 %) | 0.524 |
| Bilateral aspergilloma | 0 | 2 (4 %) | 0.350 |
Surgical performed procedures in aspergilloma cases
| Surgery | Group A ( | Group B ( |
|
|---|---|---|---|
| Wedge resection | 16 | 36 | 0.001 |
| Segementectomy by VATS | 0 | 2 | 0.512 |
| Lobectomy | 27 | 15 | 0.263 |
| pneumonectomy | 11 | 0 | 0.026 |
| cavernostomy | 2 | 0 | 0.362 |
| Myoplasty after lobectomy | 5 | 1 | 0.003 |
Postoperative morbidity and mortality
| Post operative complications | Group A( | Group B ( |
|
|---|---|---|---|
| Mortality | 2 (3.27 %) | 0 | 0.312 |
| pyothorax | 4 (6.55 %) | 2 (3.7 %) | 0.257 |
| Residual cavity | 9 (14.75 %) | 1 (1.8 %) | 0.015 |
| Bronchopleural fistula | 4 (6.55 %) | 0 | 0.311 |
| hemothorax | 3 (4.9 %) | 2 (3.7 %) | 0.353 |
| Total morbidity | 16 ( 26.6 %) | 5 (9.25 %) | 0.026 |